Zuraw B
39  Ergebnisse:
Personensuche X
?
3

The international WAO/EAACI guideline for the management of..:

Maurer, Marcus ; Magerl, Markus ; Betschel, S...
Allergy. European journal of allergy and clinical immunology.  , 2022
 
?
4

Long-Term Outcomes with Subcutaneous C1-Inhibitor Replaceme..:

Craig, T ; Zuraw, B ; Longhurst, H...
https://discovery.ucl.ac.uk/id/eprint/10089106/1/1-s2.0-S2213219819301631-main.pdf.  , 2019
 
?
5

Long-Term Outcomes with Subcutaneous C1-Inhibitor Replaceme..:

Craig T ; Zuraw B ; Longhurst H...
info:eu-repo/semantics/altIdentifier/pmid/30772477.  , 2019
 
?
6

Treatment effect of switching from intravenous to subcutane..:

Craig T ; Lumry W ; Cicardi M...
info:eu-repo/semantics/altIdentifier/pmid/30660873.  , 2019
 
?
7

Population pharmacokinetics of subcutaneous C1-inhibitor fo..:

Pawaskar D ; Tortorici M. A ; Zuraw B...
info:eu-repo/semantics/altIdentifier/pmid/29998524.  , 2018
 
?
 
?
9

International consensus on the diagnosis and management of ..:

Farkas, H ; Martinez-Saguer, I ; Bork, K...
Allergy--0105-4538--1398-9995 Vol. 72 Issue. 2 No. pp: 300-313.  , 2017
 
?
10

Corticosteroid-induced gene expression in allergen-challeng..:

Kelly, MM ; King, EM ; Rider, CF...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3372826.  , 2012
 
?
11

Bradykinin stimulates NF-kappaB activation and interleukin ..:

Pan, Z K ; Zuraw, B L ; Lung, C C...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC507648.  , 1996
 
?
 
?
13

Demonstration of modified inactive first component of compl..:

Zuraw, B L ; Curd, J G
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC423595.  , 1986
 
?
 
?
 
1-15